Neupath Health Stock Today
| NPTH Stock | CAD 0.16 0.01 5.88% |
Performance0 of 100
| Odds Of DistressLess than 23
|
NeuPath Health is selling for under 0.16 as of the 22nd of November 2024; that is 5.88 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.16. NeuPath Health has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for NeuPath Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.. The company has 56.39 M outstanding shares of which 158 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions. More on NeuPath Health
Moving against NeuPath Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
NeuPath Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NeuPath Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NeuPath Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | ||||
NeuPath Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to NeuPath Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsNeuPath Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NeuPath Health's financial leverage. It provides some insight into what part of NeuPath Health's total assets is financed by creditors.
| |||||
NeuPath Health (NPTH) is traded on TSX Venture Exchange in Canada and employs 156 people. NeuPath Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeuPath Health's market, we take the total number of its shares issued and multiply it by NeuPath Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NeuPath Health operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 56.39 M outstanding shares of which 158 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions.
NeuPath Health has accumulated about 7.48 M in cash with 3.03 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check NeuPath Health Probability Of Bankruptcy
Ownership AllocationNeuPath Health maintains a total of 56.39 Million outstanding shares. Roughly 74.78 % of NeuPath Health outstanding shares are held by general public with 0.98 pct. owned by insiders and only 24.24 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NeuPath Ownership Details
NeuPath Health Risk Profiles
Although NeuPath Health's alpha and beta are two of the key measurements used to evaluate NeuPath Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.22 | |||
| Standard Deviation | 3.46 | |||
| Variance | 11.99 | |||
| Risk Adjusted Performance | (0.05) |
NeuPath Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in NeuPath Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.